Sandbox g37: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi- (talk | contribs) Created page with " * Deep neck infection :* Empiric antimicrobial therapy ::* Community-acquired deep neck infection :::* Preferred regimen: Ampicillin-Sulbactam 1.5–3.0 g IV q6h {{or}} [..." |
Gerald Chi- (talk | contribs) mNo edit summary |
||
| Line 1: | Line 1: | ||
* Deep neck infection | * Deep neck infection | ||
:* Empiric antimicrobial therapy | :* Empiric antimicrobial therapy | ||
| Line 13: | Line 12: | ||
::* Necrotizing fasciitis | ::* Necrotizing fasciitis | ||
:::* Preferred regimen: [[Ceftriaxone]] 2.0 g IV q8h {{and}} [[Clindamycin]] 600–900 mg IV q8h {{and}} [[Metronidazole]] 500 mg IV q6h | :::* Preferred regimen: [[Ceftriaxone]] 2.0 g IV q8h {{and}} [[Clindamycin]] 600–900 mg IV q8h {{and}} [[Metronidazole]] 500 mg IV q6h | ||
:* Specific anatomic considerations | |||
::* | |||
Revision as of 06:17, 11 June 2015
- Deep neck infection
- Empiric antimicrobial therapy
- Community-acquired deep neck infection
- Preferred regimen: Ampicillin-Sulbactam 1.5–3.0 g IV q6h OR Clindamycin 600–900 mg IV q8h OR Moxifloxacin 400 mg daily (if Eikenella is suspected)
- Nosocomial deep neck infection or immunocompromised host
- Preferred regimen: Ticarcillin-Clavulanate 3.0 g IV q6h OR Piperacillin-Tazobactam 3.0 g IV q6h OR Imipenem-Cilastatin 500 mg IV q6h OR Ciprofloxacin 400 mg IV q12h OR Levofloxacin 750 mg IV q24h
- Deep neck infection with high-risk of MRSA
- Preferred regimen: (Clindamycin 600–900 mg IV q8h OR Trimethoprim-Sulfamethoxazole 10 mg/kg/day IV q8h) AND Vancomycin 1.0 g IV q12h
- Necrotizing fasciitis
- Preferred regimen: Ceftriaxone 2.0 g IV q8h AND Clindamycin 600–900 mg IV q8h AND Metronidazole 500 mg IV q6h
- Specific anatomic considerations